Filings under LGVN by Logicvision Inc (CIK 0001041418) from Feb 15, 2006 to Aug 18, 2009 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Hare Joshua | Chief Scientific Officer, Director, 10% Owner | Grant(A) | 286K | — | $0 |
| Aug 19, 2026 | Ascheim Deborah | Director | Grant(A) | 36K | — | $0 |
| Aug 19, 2026 | Agafonova Nataliya | Chief Medical Officer | Grant(A) | 286K | — | $0 |
| Aug 19, 2026 | Blass Devin | CTO & SVP of CMC | Grant(A) | 286K | — | $0 |
| Aug 19, 2026 | Cann Leah Rush | Director | Grant(A) | 36K | — | $0 |
| Aug 19, 2026 | Ungaro Ursula | Director | Grant(A) | 36K | — | $0 |
| Aug 19, 2026 | Paletta George A. Jr. | Director | Grant(A) | 36K | — | $0 |
| Aug 19, 2026 | Soffer Rock | Director | Grant(A) | 36K | — | $0 |
| Aug 19, 2026 | Hajjar Roger Joseph | Director | Grant(A) | 36K | — | $0 |
| Aug 19, 2026 | Lehr Paul T | General Counsel, Secretary | Grant(A) | 286K | — | $0 |
| Aug 19, 2026 | Desai Arjun JJ | Director | Grant(A) | 36K | — | $0 |
| Aug 17, 2026 | Jhaveri Nirav S. | Chief Financial Officer | Grant(A) | 300K | — | $0 |
| Jul 6, 2026 | Hare Joshua | Chief Scientific Officer, Director, 10% Owner | Grant(A) | 600K | — | $0 |
| Jul 6, 2026 | Hare Joshua | Chief Scientific Officer, Director, 10% Owner | Grant(A) | 400K | — | $0 |
| Jul 1, 2026 | Willard Stephen H | Chief Executive Officer | Tax withholding(F) | 18K | $0.73 | $13K |
| Jul 1, 2026 | Locklear Lisa | Chief Financial Officer | Tax withholding(F) | 23K | $0.73 | $16K |
| Jul 1, 2026 | Agafonova Nataliya | Chief Medical Officer | Tax withholding(F) | 23K | $0.73 | $16K |
| Jul 1, 2026 | Blass Devin | CTO & SVP of CMC | Tax withholding(F) | 16K | $0.73 | $12K |
| Jul 1, 2026 | Lehr Paul T | General Counsel, Secretary | Tax withholding(F) | 13K | $0.73 | $10K |
| May 1, 2026 | Blass Devin | CTO & SVP of CMC | Grant(A) | 250K | — | $0 |
| May 1, 2026 | Agafonova Nataliya | Chief Medical Officer | Grant(A) | 250K | — | $0 |
| May 1, 2026 | Lehr Paul T | General Counsel, Secretary | Grant(A) | 250K | — | $0 |
| May 1, 2026 | Locklear Lisa | Chief Financial Officer | Grant(A) | 250K | — | $0 |
| May 1, 2026 | Willard Stephen H | Chief Executive Officer | Grant(A) | 500K | — | $0 |
| Apr 1, 2026 | Blass Devin | CTO & SVP of CMC | Tax withholding(F) | 9K | $1.12 | $10K |
| Apr 1, 2026 | Agafonova Nataliya | Chief Medical Officer | Tax withholding(F) | 13K | $1.12 | $15K |
| Apr 1, 2026 | Lehr Paul T | General Counsel, Secretary | Tax withholding(F) | 6K | $1.12 | $6K |
| Apr 1, 2026 | Locklear Lisa | Chief Financial Officer | Tax withholding(F) | 13K | $1.12 | $15K |
| Apr 1, 2026 | Willard Stephen H | Chief Executive Officer | Tax withholding(F) | 5K | $1.12 | $5K |
| Mar 2, 2026 | Willard Stephen H | Chief Executive Officer | Grant(A) | 200K | — | $0 |
| Mar 2, 2026 | Willard Stephen H | Chief Executive Officer | Grant(A) | 200K | — | $0 |
| Mar 2, 2026 | Willard Stephen H | Chief Executive Officer | Tax withholding(F) | 106K | $0.55 | $58K |
| Mar 2, 2026 | Willard Stephen H | Chief Executive Officer | Grant(A) | 200K | — | $0 |
| Jan 2, 2026 | Powell James Nathaniel | Chief Executive Officer | Tax withholding(F) | 2K | $0.59 | $1K |
| Jan 2, 2026 | Blass Devin | CTO & SVP of CMC | Tax withholding(F) | 11K | $0.59 | $6K |
| Jan 2, 2026 | Locklear Lisa | Chief Financial Officer | Tax withholding(F) | 10K | $0.59 | $6K |
| Jan 2, 2026 | Lehr Paul T | General Counsel, Secretary | Tax withholding(F) | 7K | $0.59 | $4K |
| Jan 2, 2026 | Agafonova Nataliya | Chief Medical Officer | Tax withholding(F) | 10K | $0.59 | $6K |
| Oct 1, 2025 | Locklear Lisa | Chief Financial Officer | Tax withholding(F) | 12K | $0.74 | $9K |
| Oct 1, 2025 | Blass Devin | CTO & SVP of CMC | Tax withholding(F) | 8K | $0.74 | $6K |
| Oct 1, 2025 | Lehr Paul T | General Counsel, Secretary | Tax withholding(F) | 5K | $0.74 | $4K |
| Oct 1, 2025 | Powell James Nathaniel | Chief Executive Officer | Tax withholding(F) | 2K | $0.74 | $2K |
| Oct 1, 2025 | Agafonova Nataliya | Chief Medical Officer | Tax withholding(F) | 12K | $0.74 | $9K |
| Oct 1, 2025 | Paletta George A. Jr. | Director | Grant(A) | 34K | — | $0 |
| Sep 4, 2025 | Powell James Nathaniel | Chief Executive Officer | Grant(A) | 50K | — | $0 |
| Sep 4, 2025 | Powell James Nathaniel | Chief Executive Officer | Grant(A) | 20K | — | $0 |
| Aug 11, 2025 | Baluch Khoso | Director | Buy(P) | 12K | — | — |
| Aug 11, 2025 | Baluch Khoso | Director | Buy(P) | 29K | — | — |
| Aug 11, 2025 | Locklear Lisa | Chief Financial Officer | Buy(P) | 12K | — | — |
| Aug 11, 2025 | Locklear Lisa | Chief Financial Officer | Buy(P) | 29K | — | — |
| Jul 15, 2025 | Ungaro Ursula | Director | Grant(A) | 17K | — | $0 |
| Jul 15, 2025 | Motwani Neha J. | Director | Grant(A) | 17K | — | $0 |
| Jul 15, 2025 | Kender Richard N | Director | Grant(A) | 17K | — | $0 |
| Jul 15, 2025 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Grant(A) | 180K | — | $0 |
| Jul 15, 2025 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Grant(A) | 60K | — | $0 |
| Jul 15, 2025 | Baluch Khoso | Director | Grant(A) | 17K | — | $0 |
| Jul 15, 2025 | Blass Devin | CTO & SVP of CMC | Grant(A) | 102K | — | $0 |
| Jul 15, 2025 | Blass Devin | CTO & SVP of CMC | Grant(A) | 34K | — | $0 |
| Jul 15, 2025 | Locklear Lisa | Chief Financial Officer | Grant(A) | 102K | — | $0 |
| Jul 15, 2025 | Locklear Lisa | Chief Financial Officer | Grant(A) | 34K | — | $0 |
| Jul 15, 2025 | Lehr Paul T | General Counsel, Secretary | Grant(A) | 102K | — | $0 |
| Jul 15, 2025 | Lehr Paul T | General Counsel, Secretary | Grant(A) | 34K | — | $0 |
| Jul 15, 2025 | Hajjar Roger Joseph | Director | Grant(A) | 17K | — | $0 |
| Jul 15, 2025 | Agafonova Nataliya | Chief Medical Officer | Grant(A) | 102K | — | $0 |
| Jul 15, 2025 | Agafonova Nataliya | Chief Medical Officer | Grant(A) | 34K | — | $0 |
| Jul 15, 2025 | Soffer Rock | Director | Grant(A) | 17K | — | $0 |
| Jul 15, 2025 | Hare Joshua | Chief Scientific Officer, Director, 10% Owner | Grant(A) | 109K | — | $0 |
| Jul 1, 2025 | Hare Joshua | Chief Scientific Officer, Director, 10% Owner | Grant(A) | 49K | — | $0 |
| Jul 1, 2025 | Lehr Paul T | General Counsel, Secretary | Tax withholding(F) | 2K | $1.28 | $2K |
| Jul 1, 2025 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Tax withholding(F) | 13K | $1.28 | $17K |
| Jul 1, 2025 | Blass Devin | CTO & SVP of CMC | Tax withholding(F) | 5K | $1.28 | $6K |
| Jul 1, 2025 | Agafonova Nataliya | Chief Medical Officer | Tax withholding(F) | 7K | $1.28 | $10K |
| Jul 1, 2025 | Locklear Lisa | Chief Financial Officer | Tax withholding(F) | 7K | $1.28 | $10K |
| Jun 23, 2025 | Lehr Paul T | General Counsel, Secretary | Tax withholding(F) | 64K | $1.15 | $74K |
| Jun 23, 2025 | Lehr Paul T | General Counsel, Secretary | Grant(A) | 163K | — | $0 |
| Jun 13, 2025 | Hare Joshua | Chief Scientific Officer, Director, 10% Owner | Grant(A) | 185K | — | $0 |
| Jun 13, 2025 | Hare Joshua | Chief Scientific Officer, Director, 10% Owner | Grant(A) | 71K | — | $0 |
| May 30, 2025 | Soffer Rock | Director | Sell(S) | 11K | $1.25 | $14K |
| May 29, 2025 | Soffer Rock | Director | Sell(S) | 10K | $1.30 | $13K |
| May 22, 2025 | Soffer Rock | Director | Sell(S) | 2K | $1.32 | $3K |
| May 16, 2025 | Hare Joshua | Chief Scientific Officer, Director, 10% Owner | Sell(S) | 5K | $1.40 | $7K |
| Apr 1, 2025 | Lehr Paul T | General Counsel, Secretary | Tax withholding(F) | 2K | $1.50 | $2K |
| Apr 1, 2025 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Tax withholding(F) | 13K | $1.50 | $20K |
| Apr 1, 2025 | Locklear Lisa | Chief Financial Officer | Tax withholding(F) | 8K | $1.50 | $11K |
| Apr 1, 2025 | Agafonova Nataliya | Chief Medical Officer | Tax withholding(F) | 8K | $1.50 | $11K |
| Jan 2, 2025 | Lehr Paul T | General Counsel, Secretary | Tax withholding(F) | 1K | $1.79 | $2K |
| Jan 2, 2025 | Locklear Lisa | Chief Financial Officer | Tax withholding(F) | 6K | $1.79 | $11K |
| Jan 2, 2025 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Tax withholding(F) | 11K | $1.79 | $19K |
| Jan 2, 2025 | Agafonova Nataliya | Chief Medical Officer | Tax withholding(F) | 6K | $1.79 | $11K |
| Dec 2, 2024 | Baluch Khoso | Director | Sell(S) | 1K | $2.07 | $3K |
| Oct 1, 2024 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Tax withholding(F) | 13K | $1.88 | $25K |
| Oct 1, 2024 | Lehr Paul T | General Counsel, Secretary | Tax withholding(F) | 990 | $1.88 | $2K |
| Oct 1, 2024 | Agafonova Nataliya | Chief Medical Officer | Tax withholding(F) | 5K | $1.88 | $10K |
| Oct 1, 2024 | Locklear Lisa | Chief Financial Officer | Tax withholding(F) | 5K | $1.88 | $10K |
| Aug 15, 2024 | Hare Neil E | Director | Grant(A) | 24K | — | $0 |
| Aug 15, 2024 | Soffer Rock | Director | Grant(A) | 24K | — | $0 |
| Aug 15, 2024 | Ungaro Ursula | Director | Grant(A) | 24K | — | $0 |
| Aug 15, 2024 | Baluch Khoso | Director | Grant(A) | 24K | — | $0 |
| Aug 15, 2024 | Hare Joshua | Chief Scientific Officer, Director, 10% Owner | Grant(A) | 94K | — | $0 |
| Aug 15, 2024 | Hare Joshua | Chief Scientific Officer, Director, 10% Owner | Grant(A) | 7K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Longeveron Inc., SEC CIK 0001721484. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under LGVN and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-09. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for LGVN